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Convergent evolution dictates that diverse groups of viruses will
target both similar and distinct host pathways to manipulate the
immune response and improve infection. In this study, we
sought to leverage this uneven viral antagonism to identify
critical host factors that govern disease outcome. Utilizing a
systems-based approach, we examined differential regulation of
IFN-γ–dependent genes following infection with robust respira-
tory viruses including influenza viruses [A/influenza/Vietnam/
1203/2004 (H5N1-VN1203) and A/influenza/California/04/2009 (H1N1-
CA04)] and coronaviruses [severe acute respiratory syndrome
coronavirus (SARS-CoV) and Middle East respiratory syndrome
CoV (MERS-CoV)]. Categorizing by function, we observed down-
regulation of gene expression associated with antigen presenta-
tion following both H5N1-VN1203 and MERS-CoV infection. Further
examination revealed global down-regulation of antigen-presentation
gene expression, which was confirmed by proteomics for both H5N1-
VN1203 and MERS-CoV infection. Importantly, epigenetic analysis
suggested that DNA methylation, rather than histone modification,
plays a crucial role in MERS-CoV–mediated antagonism of antigen-
presentation gene expression; in contrast, H5N1-VN1203 likely uti-
lizes a combination of epigenetic mechanisms to target antigen pre-
sentation. Together, the results indicate a common mechanism
utilized by H5N1-VN1203 and MERS-CoV to modulate antigen pre-
sentation and the host adaptive immune response.
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Since the beginning of the new century, the emergence ofnovel influenza and coronavirus (CoV) strains has led to
Previously, our group used a combination of virologic, tran-
scriptomic, and proteomic data to identify differences in the global
type I IFN-stimulated gene (ISG) response across infections with
A/influenza/California/04/2009 (H1N1; herein H1N1-09), A/influenza/
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significant pandemics and poses a continuing threat to global 
public health (1–3). Understanding how these respiratory patho-
gens induce disease is key for treatment and prevention strategies 
(1). For successful respiratory viruses, multiple elements of the 
host immune response must be overcome, including both innate 
and adaptive immunity (1, 3). While these immune mechanisms 
are relatively conserved, complex interactions govern disease 
outcome, and successful viruses use a combination of approaches 
to combat host immunity. Even among related viruses, diverse 
strategies may produce similar infection results through distinct 
mechanisms (4). Therefore, susceptibility to a host pathway may 
not be uniform across a viral family or apply to all viruses infecting 
the same tissue. In exploring these responses, cross-comparisons 
may identify common strategies used by different viruses to an-
tagonize the host immune responses. In our approach, we sought 
to leverage differences and similarities between respiratory path-
ogens to identify novel viral antagonism strategies (5).
Vietnam/1203/2004 (H5N1; herein H5N1-VN1203), severe acute
respiratory syndrome CoV (SARS-CoV), and Middle East re-
spiratory syndrome CoV (MERS-CoV) (6). Our results found that
a subset of ISGs was down-regulated by both H5N1-VN1203 and
MERS-CoV, despite intact host signaling and transcriptional factor
activation. Importantly, repressive histone markers were associated
with down-regulated genes and suggested that both MERS-CoV and
H5N1-VN1203 use epigenetic modifications to modulate ISG stimu-
lation. These results correspond with reports for other viruses and
suggest epigenetics as a new horizon for viral antagonism (7, 8).
In this study, we expanded upon our previous approach to ex-
plore IFN-γ–dependent gene expression following pathogenic
influenza and CoV infection (6). Dividing differentially expressed
genes by function, we observed down-regulation of IFN-
γ–associated antigen-presentation gene expression following
both H5N1-VN1203 and MERS-CoV infection. When all ma-
jor histocompatibility complex (MHC) molecules and antigen-
presentation genes were considered, the data demonstrated
global down-regulation of gene expression that was confirmed by
proteomic analysis. However, in contrast to the mechanisms
controlling ISG expression (6), analysis of histone modifications
did not reveal Increases in either activating or repressive markers
following MERS-CoV infection. Instead, changes in DNA meth-
ylation likely facilitate MERS-CoV–mediated down-regulation of
antigen-presentation molecules. For H5N1-VN1203, both histone
modification and DNA methylation may play a role through the
activity of viral NS1. In contrast, MERS-CoV accessory ORF
mutants maintain gene expression down-regulation despite robust
attenuation in virus growth. Together, these results highlight epi-
genetic modification as an important means by which respiratory
viruses modulate host immunity.
Results
Having previously identified type I IFN-dependent genes specific
to the human airway epithelial cell line Calu3 cells (6), the same
approach was applied to define genes responsive to IFN-γ. While
some reports have indicated production by epithelial cells (9),
RNA expression data indicated no IFN-γ signal following infection
of Calu3 cells. However, responses to IFN-γ have been shown to be
critical in the innate and adaptive immune response to respiratory
infection, and epithelial cell IFN-γ responses may play a key role
during infection (10–14). Calu3 cells, treated with recombinant
IFN-γ, induced differential expression (DE) of 426 genes
[logtwofold change (FC) of >1.5, adjusted P value < 0.05]. Using
these data, we developed a consensus IFN-γ–responsive list from
the 136 genes induced at more than one time point (Table S1).
While significant overlap was observed with type I IFN-responsive
genes (42 of 136, 31%) (6), consensus IFN-γ genes also induced
transcription factors, apoptosis/cell survival genes, ubiquitination
machinery, and genes within other functional categories (Table 1).
The consensus IFN-γ gene list was then used to examine expression
changes following infection with successful respiratory viruses.
Despite the absence of IFN-γ signal in these cultures, infection with
influenza H1N1-09, H5N1-VN1203, SARS-CoV, and MERS-CoV
induced expression of IFN-γ–responsive genes by other factors;
however, these IFN-γ–responsive gene expressions varied across
viral infections, despite similar kinetics of replication (Fig. 1). For
H1N1-09 and SARS-CoV, the majority of IFN-γ–responsive genes
were strongly up-regulated, with only ∼10% exhibiting down-
regulation. In contrast, >40% of these same genes were down-
regulated by H5N1-VN1203 and MERS-CoV. Examining the
IFN-γ–responsive genes by functional subsets revealed multiple
gene groups targeted for down-regulation (Table 1). Most notable
for both H5N1-VN1203 and MERS-CoV infection were genes
associated with antigen presentation, including several MHC mol-
ecules; 80% or more of the IFN-γ–responsive genes associated with
antigen presentation were down-regulated following H5N1-VN1203 or
MERS-CoV infection (Table 1). In contrast, <10% of these genes
were down-regulated following either H1N1-09 or SARS-CoV in-
fection. Together, the results suggest strong down-regulation of
antigen-presentation genes following both H5N1-VN1203 and
MERS-CoV infection.
Down-Regulation of Antigen-Presentation Gene Expression and the MHC
Locus. We next sought to determine whether down-regulation of
antigen presentation was limited to IFN-γ–responsive genes or could
be detected across the entire spectrum of antigen-presentation
molecules. Therefore, we next examined gene expression of both
MHC molecules and other components associated with antigen
presentation; the majority of these genes were located within the
MHC locus on human chromosome 6 (chr. 6), while others were
interspersed throughout the genome (Table S2). The results in-
dicated broad down-regulation of antigen-presentation molecules
following both H5N1-VN1203 and MERS-CoV infection (Fig. 2).
In contrast, H1N1-09 infection had no effect or strongly increased
expression of these genes; similarly, SARS-CoV also induced ex-
pression for the majority of these genes. Globally, both H5N1-
VN1203 and MERS-CoV infection resulted in reduced expression
of both MHC class I and II molecules. Similarly, the expression of
other genes involved in antigen presentation, including transcrip-
tion factors (CTIIA) and machinery (TAP2 and PDIA3), both in the
MHC locus and on other chromosomes (distant), was also strongly
down-regulated. Importantly, while adjacent genes on chr. 6 not
involved in antigen presentation and MHC class III genes (com-
plement, TNF, etc.) had some modulation, down-regulation was
not uniform, suggesting specific targeting of MHC and antigen-
presentation molecules by both H5N1-VN1203 and MERS-CoV.
Proteomics Confirms Broad Down-Regulation of Antigen-Presentation
Genes. In parallel to RNA expression analyses, antigen-presentation
components were examined within the context of global proteo-
mics. As expected, peptides associated with antigen-presentation-
related molecules were detected in baseline mock-infected pro-
teomic samples. Consistent with transcriptomic data, peptides
mapping to class I MHC proteins (HLA-A, -B, or -C) exhibited
statistically significant decreases after MERS-CoV or H5N1-
VN1203 infection, but were significantly increased in cells infected
with SARS-CoV or H1N1-09 (Fig. 3). Interestingly, while MERS-
CoV infection strongly down-regulated HLA-A, -B, and -C pep-
tides, H5N1-VN1203 infection consistently down-regulated
HLA-A and -C, but not HLA-B, peptides (Fig. 3). Peptides
Table 1. Down-regulated IFN-γ–responsive genes by
classification
Category
Percentage of down-regulated type II IFN
consensus genes by category
H5N1, % H1N1, % SARS, % MERS, %
Apoptosis 60 40 0 60
Complement 57.1 0 14.3 54.1
Cytokine 11.1 11.1 11.1 33.3
Lipid proteins 67 22.2 33.3 88.9
MHC 86.7 6.6 6.6 80
ISG 18.2 0 0 18.2
Nucleotide binding
proteins
37.5 0 0 37.5
Receptors 66.7 33.3 0 50
Transcriptional factors 60 10 0 30
Ubiquitin 60 0 0 40
Unclassified 35.2 29.4 23.5 58.8
IFN-γ–responsive gene divided into functional categories and classified as
either up-regulated (log2 FC > 0) or down-regulated (log2 FC < 0). Boldface,
MHC and antigen presentation-related molecules had >80% down-
regulation in both H5N1-VN1203 and MERS-CoV (n = 15 genes).
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and identified histone modification patterns for all genes on chr.
6, which contains the MHC locus. In H5N1-VN1203 infections,
we observed depletion of H3K4 trimethylation across the length
of chr. 6, with the strongest depletion in parts of the MHC locus
(Fig. 4C). Concurrently, few chr. 6 genes exhibited substantial
depletion of H3K27 trimethylation (Fig. S1A), and some were
enriched for H3K27me3 (Fig. S1B). Taken together, these
Fig. 1. Type II IFN treatment and diverse respiratory virus infections result in robust expression differences. Global transcriptional response of consensus
genes following IFN-γ treatment or infection with H5N1-VN1203, H1N1-09, SARS-CoV, and MERS-CoV is shown. Genes were ordered by functional groups.
Values represent logtwofold change compared with time-matched mock-infected samples.
Fig. 2. Both H5N1-VN1203 and MERS-CoV down-regulate genes within the
MHC locus and associated with antigen presentation. Global transcriptional
response of gene located within the MHC locus on chr. 6 (MHC class I, II, III,
and adjacent genes) or distant genes (not located on chr. 6) associated with
antigen presentation following infection with H5N1-VN1203, H1N1-09,
SARS-CoV, and MERS-CoV is shown. Genes are ordered by MERS-CoV ex-
pression levels at 24 hpi. Values represent logtwofold change compared with
time-matched mock-infected samples.
associated with other (non-HLA) antigen-presentation pro-
teins exhibited similar overall expression patterns (Fig. 3A). 
Together, the transcriptomic and proteomic data indicate 
that antigen-presentation molecule expression is antagonized 
by MERS-CoV and H5N1-VN1203 infections—with some 
potential differences in efficiency or mechanism of antago-
nism—but not by SARS-CoV and H1N1-09 infections.
Histone Modification Does Not Drive MERS-CoV–Mediated MHC Down-
Regulation. Previously, we demonstrated that a subset of type I ISGs 
are down-regulated by H5N1-VN1203 and MERS-CoV infections, 
and our results implicated alterations in histone modification in 
driving differential ISG expression (6). To determine whether histone 
modifications also affect antigen-presentation gene expression, we 
examined enrichment of activating (H3K4me3) and repressive 
(H3K27me3) methylation markers on the 5′ promoters of MHC class 
I (HLA-A), II (HLA-DRB), and III (LTA) molecules in lysates from 
cells infected with SARS-CoV, MERS-CoV, H5N1-VN1203, or 
H1N1-09 using a chromatin immunoprecipitation-PCR (ChIP-PCR)–
based approach. For the activating histone marker (H3K4me3), en-
richment was observed only in HLA-A promoter regions following 
H1N1-09 and H5N1-VN1203 infection, and no enrichment or loss of 
H3K4 trimethylation was observed for HLA-DRB1 or LTA pro-
moters following either influenza virus infection (Fig. 4A). SARS-
CoV infections did not result in significant enrichment or loss of 
H3K4me3 for any of these genes. In contrast, MERS-CoV infection 
reduced H3K4 trimethylation for all three genes, with significant 
changes observed in HLA-DRB1 and LTA promoter regions. For 
all three promoter regions, strong reductions in the repressive 
marker (H3K27me3) were also observed following SARS-CoV 
and MERS-CoV infections (Fig. 4B); similarly, H1N1-09 and 
H5N1-VN1203 also reduced repressive marks for the HLA mol-
ecules. Together, the data suggest that modest transcriptional 
activation was possible if H3K4me3 motifs remained intact.
To expand on this these findings for high-pathogenicity viruses 
(H5N1-VN1203 and MERS-CoV), we next performed ChIP-
sequencing (ChIP-seq) analysis for H3K4me3 and H3K27me3
ablates expression, indirectly leading to reduced access and loss of
histone marks. To examine this possibility, we performed methylated
DNA-IPs (MeDIPs) with virus-infected cells and then assessed the
methylation status of three antigen-presentation-associated gene
promoters (HLA-A, B2M, and PDIA3) using PCR (Fig. 5A). For
H1N1-09, infection resulted in modest changes, with increased
methylation of HLA-A and reduced methylation of B2M promoter
regions. Similarly, SARS-CoV infection generally resulted in mod-
est DNA methylation trending toward reduced methylation relative
to mock-infected controls. In contrast, H5N1-VN1203 infection
increased methylated DNA levels in the same target genes, and,
strikingly, MERS-CoV infection resulted in complete methylation
(100%) of all three target genes. To verify the effect observed
in MERS-CoV infections, we performed MeDIP-PCR reactions
for three additional antigen-presentation gene promoters (CIITA,
HLA-E, and PSMB9) and again observed complete promoter
Fig. 3. Proteomics analysis confirmed down-regulation of MHC class I-associated molecules following H5N1-VN1203 and MERS-CoV infection. (A) Differential
abundance analysis comparing virus to time-matched mock samples with statistically significant increases represented in red and decreases in blue (P values
based on logtwofold changes, flagged for statistical significance based on P ≤ 0.05). P values are derived from ANOVA (quantitative comparison) when
enough data are present; otherwise, P values are from the g test (qualitative comparison). (B–D) Peptide abundance normalized to mock for HLA-A (B), HLA-B
(C), and HLA-C (D) molecules following infection with H1N1-09 (red), H5N1-VN1203 (blue), SARS-CoV (green), and MERS-CoV (orange). Each point represents
peptide associated with an HLA molecule class and line plotted for average of multiple peptides.
observations suggest that H5N1-VN1203 infection may reduce the 
potential for transcriptional activation of chr. 6 genes, particularly 
within the MHC locus, and further implies that histone alterations 
may contribute to H5N1-VN1203–mediated down-regulation of 
antigen-presentation gene expression. For MERS-CoV, histone 
modification data offer a muddled picture, with enrichment and 
depletion found for both activating and repressive markers (Fig. S1). 
Coupled with the ChIP-PCR of the promoter regions, these results 
suggest that histone modifications are not the driver of MERS-
CoV–mediated antagonism of antigen presentation.
DNA Methylation Contributes to Antagonism of Antigen Presentation. 
While reduced histone modifications following MERS-CoV in-
fection failed to explain down-regulation of antigen-presentation 
molecules, it suggested an alternative epigenetic mechanism: 
DNA methylation. Direct methylation of genomic DNA functionally
∼3.464-Mbp MHC locus maintained 49.11 meCpGs/Mbp. In
contrast, the remainder of chr. 6 averaged 19.54 meCpGs/
Mbp following MERS-CoV infection. Similarly, examination
of other chromosomes (Table S3) found lower meCpG/Mbp rates,
suggesting specificity in the magnitude of DNA methylation at the
MHC locus and potentially other genomic locations. Similarly,
H5N1-VN1203 methylation within the MHC locus corresponded to
34.29 meCpG/Mbp vs. 7.7 meCpG/Mbp over the remainder of the
chr. 6. Together, these results suggest that DNA methylation is at
least one of the primary mechanisms exploited by MERS-CoV to
antagonize antigen-presentation gene expression in infected cells,
while H5N1-VN1203 may use a combination of DNA methylation
and histone-modification alterations to achieve a similar affect.
Fig. 4. Altered histone modifications play a role in H5N1-VN1203 influenza, but not MERS-CoV antagonism of antigen presentation. (A and B) ChIP with
antibodies against H3K4me3 (A) or H3K27me3 (B) followed by qPCR of the 5′ UTR of the identified genes 18 hpi with H1N1-09 (red), H5N1-VN1203 (blue),
SARS-CoV (green), or MERS-CoV (orange). Values represent fold increase binding compared with mock on Log2 scale. P values are based on Student’s t test
and compare individual viral infection to mock value: *P < 0.05; **P < 0.01; ***P < 0.001. (C) Chromosome plot of chr. 6 showing depletion of
H3K4 methylation following H5N1-VN1203, but not MERS-CoV, infection. Loss of H3K4 methylation was called against the time-matched mock reads as
reference reads with mock values equaling 0. H3K4 methylation depletion was then quantified and plotted as bars according the location on chr. 6; each bar
indicates total number of histone modification marks within 1 Mb.
methylation for all genes (Fig. S2). Global methylation analysis of 
chr. 6 revealed robust methylation across the entire chromosome 
following MERS-CoV infection (Fig. 5B). Importantly, while H5N1-
VN1203 infection also induced increased methylation across chr. 6, its 
peaks were less in magnitude than observed in MERS-CoV infection. 
However, it is possible that DNA methylation is due to stress 
induced by viral infection. Both MERS-CoV and H5N1-VN1203 
produced significant cytopathic effect by 24 h postinfection (hpi), 
contrasting both SARS-CoV and H1N1-09. However, while a 
global increase in methylation was observed following MERS-
CoV and H5N1-VN1203 infection, it was far from uniform 
across the entire genome. More in-depth analysis of methyl-
ation data found that, following MERS-CoV infection, the
6 A and B). While the overall peptide level was decreased relative
to mock, truncation of H5N1-VN1203 NS1 resulted in augmented
protein expression of both MHC class I molecules relative to the
WT virus. Importantly, the reduction of MHC class I down-
regulation was not a product of attenuated viral replication, as
the PB2 mutant had similar replication kinetics and titer, but
maintained HLA-A and -C antagonism (Fig. S3A). Together, the
results implicate a role for NS1 in modulation of antigen pre-
sentation following H5N1-VN1203 infection.
In contrast, results from an attenuated MERS accessory ORF
mutant virus infection suggested that host processes may con-
tribute to the modulation of host antigen presentation. The
Fig. 5. Examination of host DNA revealed complete methylation at MHC gene loci following MERS-CoV infection. (A) DNA methylation status during MERS-
CoV, SARS-CoV, H5N1, and H1N1 infection. MeDIP was performed with total DNA from Calu3 cells infected with MERS-CoV, SARS-CoV, H5N1-VN1203, or
H1N1-09 for 18 h to determine the methylation status of MHC gene promoters. Methylated CpG islands within the promoter regions for HLA-A, B2M, and
PDIA3 were quantified by qRT-PCR. Results were reported as relative percentage of methylated (red) and unmethylated (gray) DNA in each target genomic
DNA sequence for each virus. (B) Chromosome plot of chr. 6 showing DNA methylation after H5N1 and MERS-CoV infection. Differential methylation levels
were called against the time-matched mock reads as reference reads with mock values equaling 0. Methylation levels were then quantified and plotted as
bars according their location on chr. 6; each bar indicates the total number of differential methylation marks within 1 Mb.
Both Viral and Host Processes Contribute to DNA Methylation. To 
examine how these respiratory viruses target antigen presentation 
via epigenetic modulation, we utilized MERS-CoV and H5N1-
VN1203 mutants that lacked key viral proteins. Previous work by 
our group implicated influenza NS1 in histone modification and 
ISG down-regulation compared with a similarly replication at-
tenuated PB2 mutant (6). In this study, we extended this analysis 
to antagonism of antigen-presentation molecules. Following in-
fection of Calu3 cells with wild-type (WT), C-terminal truncation 
of NS1 (NS1trunc124), or PB2 encoding an amino acid sub-
stitution (PB2-K627E) mutant viruses, we examined changes in 
viral replication as well as HLA-A and -C peptide abundance 
(Fig.
observed following mock or SARS-CoV infection. However, while
H5N1-VN1203 had augmented DNA methylation relative to mock,
its overall increase was less uniform than MERS-CoV, leaving the
possibility that histone modification may also contribute to control
of antigen-presentation gene expression. Together, the data from
both MERS-CoV and H5N1-VN1203 infection suggest that mul-
tiple epigenetic mechanisms contribute to antagonism of the host
immune response.
While not definitive, mutant virus data suggest that both viral
proteins and host processes may modulate antigen presenta-
tion following MERS-CoV and H5N1-VN1203 infection. Similar
to down-regulation of ISGs (6), truncation of H5N1-VN1203
NS1 resulted in augmentation of MHC class I molecules rela-
tive to WT infection; importantly, the reduction was not a simple
product of lower viral replication, as a similarly attenuated viral
mutant maintained down-regulation of MHC class I molecules.
In contrast, a MERS-CoV mutant strain lacking all four acces-
sory ORF proteins produced robust down-regulation of both
HLA-A and -C, despite a 100-fold replication attenuation rela-
tive to WT control virus. These results suggest that MERS-CoV
entry or initial steps of infection trigger antagonism of antigen
presentation. One possibility is stimulation of host processes that
directly or indirectly result in reduction of the antigen-presentation
molecules. For example, MERS-CoV infection may stimulate de-
pression of host gene regulation, resulting in increased competition
for transcription factors driving MHC expression. Alternatively,
activation of DNA methylation pathways may be initiated by
MERS-CoV infection, resulting in regulation of host constitutive
processes as well as dipeptidyl peptidase 4 receptor expression (18).
Together, the mutant virus data from both viruses suggest that
complex host–pathogen interaction dictate epigenetic-based an-
tagonism of antigen presentation.
Targeting of host antigen presentation has significant impli-
cations for pathogenesis of both MERS-CoV and H5N1-VN1203.
Unlike SARS-CoV infection, which is limited to pneumocytes and
ciliated airway epithelium in the lung (19), MERS-CoV has broader
Fig. 6. Proteomics analysis of H5N1-VN1203 and MERS-CoV mutants suggest that both viral and host processes contribute to reduction of antigen-
presentation molecules. (A and B) Peptide abundance normalized to mock for HLA-A (A) and HLA-C (B) following infection with influenza H5N1-VN12033
WT (blue), PB2-K627E mutant (gray), or NS1-truncation (red). (C and D) Peptide abundance normalized to mock for HLA-A (C) and HLA-C (D) following in-
fection with MERS-CoV WT (orange) or accessory ORF mutant (ΔORF3-5; gray). Each point represents a peptide associated with an HLA molecule class and line
plotted for average of multiple peptides.
absence of MHC locus antagonism in SARS-CoV and other 
CoV infection suggested that a nonconserved portion of the 
MERS-CoV backbone is involved. With this in mind, we fo-
cused on the MERS-CoV accessory ORF proteins, which have 
limited sequence similarities with other CoV family proteins. 
Using a previously described MERS-CoV mutant that deletes 
all four accessory ORFs (d3-5) (15), we infected Calu3 cells 
and examined both viral replication and proteomics. Following 
infection, the d3-5 mutant virus produced robust attenuation in 
terms of viral replication (Fig. S3B). However, despite a nearly 
100-fold reduction in viral replication, the d3-5 mutant viruses 
maintained strong down-regulation of MHC class I molecules 
HLA-A and -C (Fig. 6 C and D). While not equivalent to WT 
MERS-CoV down-regulation, the d3-5 mutant maintained 
lower absolute MHC class I peptide abundance compared with 
WT H5N1-VN1203 (Fig. 6 A and B). Together, the data sug-
gest that even a robustly attenuated MERS-CoV mutant can 
stimulate down-regulation of antigen-presentation molecules 
and potentially implicate host processes in contributing to re-
duction of MHC class I molecules following infection.
Discussion
System-based analysis has previously revealed similarities and 
contrasts in terms of ISG induction between and within viral 
families (6). This study extends that approach, demonstrating
DE of IFN-γ–dependent genes following H1N1-09, H5N1-VN1203, 
SARS-CoV, and MERS-CoV infection. Expanding on the initial 
comparison, analysis of functional categories demonstrated global 
down-regulation of MHC and antigen-presentation molecules fol-
lowing both MERS-CoV and H5N1-VN1203 infection; these re-
sults correspond to MHC down-regulation reported for H5N1 in 
A549 and chicken embryonic fibroblasts (16, 17). The changes in 
RNA expression were found throughout the MHC locus and were 
confirmed by proteomic analysis in both viruses. Seeking mecha-
nistic insights, epigenetic studies captured robust increases in DNA 
methylation following MERS-CoV infection with no similar trend
systems data (34, 39). Overall, surveying contrasts in host re-
sponses between viruses represents a powerful means to un-
derstand treatment and pathogenesis.
Experimental Procedures
Cells and Viruses. Calu3 cells were utilized as described (37, 38, 40). Viral ti-
trations and propagation of SARS-CoV, MERS-CoV, and influenza virus were
performed in VeroE6, Vero-81, and Madin–Darby canine kidney (MDCK) cells
by using standard methods. WT icSARS-CoV was derived from the R.S.B.
laboratory’s infectious clone constructs (41). MERS-CoV (EMC 2012 strain)
was provided by Bart L. Haagmans, Erasmus Medical Center, Rotterdam, The
Netherlands via material transfer agreement. H5N1-VN1203 was derived
from a plasmid-based reverse-genetic system, and H1N1-09 was from WT
stock; both were subsequently amplified in MDCK cells (42).
Infections. Experiments using H5N1-VN1203, SARS-CoV, or MERS-CoV were
performed in containment laboratories at the University of Wisconsin–
Madison or University of North Carolina–Chapel Hill as described (40, 41).
Influenza and CoV infections were carried out at a multiplicity of infection
(MOI) of 1 (H5N1-VN1203), 3 (H1N1-09), and 5 (SARS-CoV and MERS-CoV) for
both WT and mutant viruses as described (37, 38, 40).
RNA Isolation, Microarray Processing, and Identification of DE. RNA isolation
and microarray processing from Calu3 cells was carried out as described (40).
DE was determined by comparing virus-infected replicates to time-matched
mock replicates. Criteria for DE in determining the consensus ISG list were an
absolute log2 fold change of >1.5 and a false discovery rate (FDR)-adjusted P
value of <0.05 for a given time point.
Proteomics Reagents, Sample Preparation, Database Construction, and Data
Processing. Proteomics preparation was carried out as described (37). De-
tailed experimental approaches have been included in Supporting In-
formation. Quality control processing was performed to identify and remove
contaminant proteins, redundant peptides, peptides with an insufficient
amount of data across the set of samples (43), and LC-MS runs that showed
significant deviation from the standard behavior of all LC-MS analyses (44).
Peptides were normalized by using a statistical procedure for the analysis of
proteomic normalization strategies that identified the peptide-selection
method and data-scaling factor which introduced the least amount of bias
into the dataset (45). The peptide abundance values were normalized across
the technical replicates by using a global median centering of the data.
Normalized log10 abundance values were averaged across the technical
replicates within each biological sample. Peptides were evaluated with a
Dunnett adjusted t test and a G test to identify quantitative and qualitative
significance patterns, respectively, in the peptide data. Peptide level signif-
icance patterns were used for protein roll-up to select appropriate peptides
for protein quantification. Proteins were quantified by using a standard
R-Rollup method using the most abundant reference peptide (46) after
filtering the peptides that were redundant, had low data content, or
were outside the dominant significance pattern.
ChIP-PCR. ChIP analysis was performed by using the EpiTect ChIP OneDay Kit
(Qiagen). Briefly, infected Calu3 cells were cross-linked, harvested, and frozen
at −80 °C. Cells were then lysed and chromatin sheared via sonication to
generate chromatin fragments between 250 and 1,000 base pairs. Sonicated
samples were then immunoprecipitated with anti-STAT1 (clone C-24; Santa
Cruz Biotechnology), anti-H3K4me3 (Qiagen), anti-H3K27me3 (Qiagen), or
anti-mouse IgG (Qiagen) as a control. To determine the histone modification
distribution, quantitative real-time PCR (qPCR) was performed by targeting
the 5′ UTR (−750 bp to transcription start site) of select genes; target and
primer information are included in Supporting Information. ChIP results
were reported as fold difference (or differential occupancy), allowing com-
parison across multiple samples. For this, each sample was normalized to the
input, and then the fold enrichment was calculated by using the ΔΔCt
method. The fold difference for each gene was determined by dividing the
appropriate time-matched mock by the experimental group. Finally, the fold
difference values were converted to log2 and plotted. Data presented are
the means ± SEs for triplicate samples.
ChIP-Seq. ChIP analysis for NGS sequencing was performed by using the
MAGnify ChIP System (Invitrogen). Briefly, for ChIP analysis, Calu3 cells were
plated (∼1.5 × 106 per well) and infected with H5N1-VN1203 or H1N1-09 at
an MOI of 5 and harvested at 0 and 12 hpi; cultures inoculated with PBS
alone served as time-matched mock controls. Sonication conditions were
tropism, infecting not only nonciliated airway epithelial cells and 
type 1/2 pneumocytes in the lung, but a number of immune cell 
populations, including T cells, macrophages, and dendritic cells in 
vitro (20–22); similarly, a number of H5N1-VN1203 strains have 
been reported to infect both macrophages and dendritic cells in 
vitro (23, 24). In the context of antigen presentation, the expanded 
tropism of both viruses potentially impacts systemic aspects of 
adaptive immunity and memory responses. For H5N1 strains, 
modulation of antigen presentation may contribute to the inefficacy 
of the CD8 T-cell response during acute infection (25) and mar-
ginal, waning memory responses overall (26). Similarly, MERS-
CoV infection has been characterized by uneven and often mar-
ginal antibody serum neutralization in recovering patients (27, 28). 
For both viruses, manipulation of antigen presentation may con-
tribute to these diminished responses and may have important 
ramifications for both vaccine designs.
For viral antagonism, the epigenetic landscape represents a 
potent and important avenue to disrupt the host immune re-
sponse (29). While always a consideration for DNA viruses that 
reside in the nucleus, recent research has focused on how viruses 
utilize aspects of the epigenetic machinery to enable persistence 
and emergence (30). In addition, several reports have high-
lighted how viruses have disrupted epigenetic regulation and 
impact the host immune response. For example, NS1 of in-
fluenza H3N2 has been implicated as a histone mimic disrupting 
the antiviral response (8). Similarly, both hepatitis C virus and 
adenoviruses have proteins that interfere with epigenetics func-
tions and alter global immune function (7, 31, 32). Previous work 
by our group found clear association of repressive histone modi-
fication H3K27me3 with down-regulated ISGs following both 
MERS-CoV and H5N1-VN1203 infection (6); subsequently, de-
spite pathway and transcription factor activation, the repressed 
state physically prevented transcription of these genes. Similarly, 
our results in this work argue that DNA methylation plays a 
similar role in the loss of antigen-presentation molecules following 
both MERS-CoV and H5N1-VN1203 infection. Importantly, the 
sequencing data suggest that other specific regions of the genome 
are also targeted by global methylation, potentially signifying 
critical pathways modulated by viral antagonism and providing a 
path for future studies. In addition, viruses may utilize distinct 
epigenetic mechanism in parallel, resulting in specific targeting of 
host ISGs by H3K27 trimethylation instead of DNA methylation 
within that genome region. Together, these results suggest that 
multiple viruses target different epigenetic processes to modulate 
aspects of host immunity and indicate that additional studies will 
be required to fully understand how epigenetics modulates the 
host immune response following virus infection.
The data in this work highlight the utility of leveraging viral 
cross-comparisons as a way to identify host factors impacting 
disease outcomes. Convergent evolution predicts that diverse 
viruses will utilize similar and divergent strategies to overcome 
common host immune responses to produce successful infections 
(33). Therefore, in leveraging available systems-based datasets, 
we seek similarities and contrast between viruses while taking 
advantage of uniform platforms, infection conditions, and data 
collection methods (34). The results have provided insights into 
both MERS-CoV and H5N1-VN1203 manipulation of IFN re-
sponses and antigen presentation. These findings provide not 
only a better understanding of the host response to infection, but 
also have the potential to aid in the development of treatment 
and prevention strategies. Future studies should expand these 
approaches to explore other specific aspects of immunity, in-
cluding inflammatory responses, apoptosis, and autophagy. 
Similarly, viral cross-comparisons can also be integrated across 
data types as well as in vitro and in vivo systems as an additional 
metric for more traditional modeling approaches (35–38). Im-
portantly, much of this analysis can occur on publicly available 
datasets, increasing both the utility and impact of already existing
chosen to result in the desired size distribution of the sonicated chromatin
between 250 and 1,000 bp. Sonicated samples were then immunoprecipi-
tated with anti-H3K4me3 (Qiagen) and anti-H3K27me3 (Qiagen). To de-
termine genome-wide histone modification, ChIP DNA was subjected to
next-generation sequencing (NGS) on a TruSeq ChIP Library Preparation
Kit (Illumina) and sequenced on an Illumina HiSeq. NGS data analysis was
performed by utilizing the CLC Genomics Workbench. The Histone ChIP-Seq
plugin provided analysis tools for a complete histone modification analysis.
Briefly, paired end reads were mapped against the human GRCh37/
hg19 reference genome by using a stringent alignment setting (mismatch
cost = 2). Peaks were called against the time-matched mock reference reads.
To determine specific genomic regions of histone modification enrichment,
the maximum P value for peak calling was set to P < 0.05 to detect regions
that had a significant fit with the peak shape.
MeDIP-PCR. Briefly, for methylated DNA analysis, Calu3 cells were plated
(∼1.5 × 106 per well) and infected with MERS-CoV, SARS-CoV, H5N1-VN1203,
or H1N1-09 at a MOI of 5 or 3 (H5N1 only). Total genomic DNA was har-
vested 0, 12, 18, and 24 hpi by using the PureLink Genomic DNA Minikit.
Cultures inoculated with PBS alone served as time-matched mock controls.
Sonication conditions were chosen to result in the desired size distribution of
the sonicated total DNA between 250 and 1,000 bp. Sonicated samples were
then used to enrich methylated DNA by using the methyl-CpG binding do-
main of human MBD2 protein (MethylMiner Methylated DNA Enrichment
Kit; Invitrogen). To determine the methylation status of MHC gene pro-
moters, qRT-PCR was performed. For this, primer pairs targeted the CpG
islands of target genes. Results were reported as the relative percentage of
methylated and unmethylated DNA in each target genomic DNA sequence
by using the ΔΔCt method. The fraction methylated of DNA in each sample
was calculated by normalizing the total DNA amount to the amount of
unmethylated DNA.
MeDIP-Seq. To determine genome-wide methylation status, enriched meth-
ylated DNA was subjected to NGS. Genomic DNA was harvested as described
above by pooling three samples, and libraries were generated by using the
TruSeq DNA Methylation Kit (Illumina) and sequenced on an Illumina HiSeq.
NGS data analysis was performed by utilizing the CLC Genomics Workbench.
The Bisulfite Sequencing plugin provided analysis tools for a complete bi-
sulfite sequencing workflow. Briefly, bisulfite paired-end reads weremapped
against the human GRCh37/hg19 reference genome by using a stringent
alignment setting (mismatch cost = 2). Methylation levels were called against
the time-matched mock reads, and resulting methylation levels of sample
and reference were compared by using a Fisher exact test (P < 0.05.)
detecting differential methylation levels.
Data Dissemination. Raw microarray data for these studies were deposited in
publicly available databases in the National Center for Biotechnology In-
formation Gene Expression Omnibus (GEO) database (37) and are accessible
through GEO accession no. GSE33267 (https://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE33267). CHIP-Seq, MeDIP-Seq, and raw proteomics
data have been made available on the Omics-LHV web portal (https://omics-
lhv.org/data/). Raw proteomics data corresponding to peptide identifications
used to populate the AMT tag database are available at the PRoteomics
IDEntification (PRIDE) database (https://www.ebi.ac.uk/pride/archive/) under
the project “A Systems Biology Approach to Emerging Respiratory Viral
Diseases” in the PRIDE Public Projects folder and corresponding to PRIDE
accession nos. 19,877–19,890. The raw quantitative proteomics data can be
accessed at the Pacific Northwest National Laboratory (PNNL) Biological
Mass Spectrometry Data and Software Distribution Center (omics.pnl.gov/)
in the Systems Virology Contract Data folder within the Browse Available
Data folder. All data sets and associated metadata have been submitted to
Virus Pathogen Resource (www.viprbrc.org/brc/home.spg?decorator=vipr).
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